Literature DB >> 23801404

The density of macrophages in colorectal cancer is inversely correlated to TGF-β1 expression and patients' survival.

Maya Gulubova1, Julian Ananiev, Yovchev Yovchev, Aleksander Julianov, Anatoli Karashmalakov, Tatyana Vlaykova.   

Abstract

The role of macrophages in colorectal cancer tumorogenesis is complex because they can both prevent and promote tumor development. We investigated CD68-positive cell infiltration in tumor tissue and its correlations with proteins of TGF-β1 signaling pathway and survival of the patients after surgical therapy. A non-selected panel of 210 primary tumors of colorectal origin was investigated immunohistochemically with antibodies against CD68, TGF-β1, TGFβRII and Smad4. Lower CD68 infiltration in tumor stroma was associated with expression of TGF-β1 (p = 0.002) and SMAD4 (p = 0.090) in tumor cell cytoplasm and with TGFβRII expression (p = 0.017) in tumor cells membranes. The absence of SMAD4 immune deposits in tumor cell nuclei was more often seen in biopsies with low number of CD68 in the invasive front (p = 0.044). The low number of CD68-positive cells was significantly associated with several adverse clinical and histological tumor characteristics as the presence of metastases in local lymph nodes (p = 0.047), distant metastases (p = 0.0003), advanced tumor stage (p = 0.006), tumor cell invasion of blood, lymph vessels or perineural invasion (p = 0.004), higher histological types (p = 0.0002) and lower grade of inflammatory infiltration in the invasive front (p = 0.002). Moreover, the low grade of CD68 appeared to be significant unfavorable factors of prognosis of the patients with colorectal cancer. The results of our study confirm the prognostic significance of low level of tumor-associated macrophage infiltration in colorectal cancer as unfavorable marker for survival of the patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23801404     DOI: 10.1007/s10735-013-9520-9

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  66 in total

Review 1.  Macrophage polarization comes of age.

Authors:  Alberto Mantovani; Antonio Sica; Massimo Locati
Journal:  Immunity       Date:  2005-10       Impact factor: 31.745

Review 2.  Differentiation and gene expression profile of tumor-associated macrophages.

Authors:  Astrid Schmieder; Julia Michel; Kathrin Schönhaar; Sergij Goerdt; Kai Schledzewski
Journal:  Semin Cancer Biol       Date:  2012-02-13       Impact factor: 15.707

3.  Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway.

Authors:  Yibin Kang; Wei He; Shaun Tulley; Gaorav P Gupta; Inna Serganova; Chang-Rung Chen; Katia Manova-Todorova; Ronald Blasberg; William L Gerald; Joan Massagué
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-19       Impact factor: 11.205

4.  Tumor-associated Macrophages (TAM) and Inflammation in Colorectal Cancer.

Authors:  Marco Erreni; Alberto Mantovani; Paola Allavena
Journal:  Cancer Microenviron       Date:  2010-09-17

Review 5.  Immune infiltration in human cancer: prognostic significance and disease control.

Authors:  Wolf H Fridman; Jérome Galon; Marie-Caroline Dieu-Nosjean; Isabelle Cremer; Sylvain Fisson; Diane Damotte; Franck Pagès; Eric Tartour; Catherine Sautès-Fridman
Journal:  Curr Top Microbiol Immunol       Date:  2011       Impact factor: 4.291

6.  Positive correlation between PEDF expression levels and macrophage density in the human prostate.

Authors:  Thomas Nelius; Christina Samathanam; Dalia Martinez-Marin; Natalie Gaines; Jessica Stevens; Johnny Hickson; Werner de Riese; Stéphanie Filleur
Journal:  Prostate       Date:  2012-10-04       Impact factor: 4.104

7.  Transforming growth factor beta can be a parameter of aggressiveness of pT1 colorectal cancer.

Authors:  Katarzyna Guzinska-Ustymowicz; Andrzej Kemona
Journal:  World J Gastroenterol       Date:  2005-02-28       Impact factor: 5.742

8.  Relationships between tumor-associated macrophages and clinicopathological factors in patients with colorectal cancer.

Authors:  Yoshifumi Nakayama; Nobuo Nagashima; Noritaka Minagawa; Yuzuru Inoue; Takefumi Katsuki; Koji Onitsuka; Tatsuhiko Sako; Keiji Hirata; Naoki Nagata; Hideaki Itoh
Journal:  Anticancer Res       Date:  2002 Nov-Dec       Impact factor: 2.480

9.  Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas.

Authors:  Y Komohara; K Ohnishi; J Kuratsu; M Takeya
Journal:  J Pathol       Date:  2008-09       Impact factor: 7.996

10.  Importance of direct macrophage-tumor cell interaction on progression of human glioma.

Authors:  Yoshihiro Komohara; Hasita Horlad; Koji Ohnishi; Yukio Fujiwara; Bing Bai; Takenobu Nakagawa; Shinya Suzu; Hideo Nakamura; Jun-ichi Kuratsu; Motohiro Takeya
Journal:  Cancer Sci       Date:  2012-10-26       Impact factor: 6.716

View more
  18 in total

1.  Over-expression of IQGAP1 indicates poor prognosis in head and neck squamous cell carcinoma.

Authors:  Cong-Cong Wu; Hao Li; Yao Xiao; Lei-Lei Yang; Lei Chen; Wei-Wei Deng; Lei Wu; Wen-Feng Zhang; Zhi-Jun Sun
Journal:  J Mol Histol       Date:  2018-05-30       Impact factor: 2.611

2.  Dual targeted immunotherapy via in vivo delivery of biohybrid RNAi-peptide nanoparticles to tumour-associated macrophages and cancer cells.

Authors:  João Conde; Chenchen Bao; Yeqi Tan; Daxiang Cui; Elazer R Edelman; Helena S Azevedo; Hugh J Byrne; Natalie Artzi; Furong Tian
Journal:  Adv Funct Mater       Date:  2015-06-01       Impact factor: 18.808

Review 3.  Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers.

Authors:  Irina Larionova; Gulnara Tuguzbaeva; Anastasia Ponomaryova; Marina Stakheyeva; Nadezhda Cherdyntseva; Valentin Pavlov; Evgeniy Choinzonov; Julia Kzhyshkowska
Journal:  Front Oncol       Date:  2020-10-22       Impact factor: 6.244

Review 4.  Prognostic value and clinicopathological roles of phenotypes of tumour-associated macrophages in colorectal cancer.

Authors:  Yamei Zhao; Xiaoxu Ge; Xiaoming Xu; Shaojun Yu; Jian Wang; Lifeng Sun
Journal:  J Cancer Res Clin Oncol       Date:  2019-10-24       Impact factor: 4.553

Review 5.  Prognostic stratification of colorectal cancer patients: current perspectives.

Authors:  Nora I Schneider; Cord Langner
Journal:  Cancer Manag Res       Date:  2014-07-02       Impact factor: 3.989

Review 6.  Pro-Tumoral Inflammatory Myeloid Cells as Emerging Therapeutic Targets.

Authors:  Gabor J Szebeni; Csaba Vizler; Lajos I Nagy; Klara Kitajka; Laszlo G Puskas
Journal:  Int J Mol Sci       Date:  2016-11-23       Impact factor: 5.923

7.  Loss of TGFβ signaling promotes colon cancer progression and tumor-associated inflammation.

Authors:  Daniel R Principe; Brian DeCant; Jonas Staudacher; Dominic Vitello; Riley J Mangan; Elizabeth A Wayne; Emman Mascariñas; Andrew M Diaz; Jessica Bauer; Ronald D McKinney; Khashayarsha Khazaie; Boris Pasche; David W Dawson; Hidayatullah G Munshi; Paul J Grippo; Barbara Jung
Journal:  Oncotarget       Date:  2017-01-17

8.  Tumor-Associated Macrophages and Regulatory T Cells Infiltration and the Clinical Outcome in Colorectal Cancer.

Authors:  Dariusz Waniczek; Zbigniew Lorenc; Mirosław Śnietura; Mariusz Wesecki; Agnieszka Kopec; Małgorzata Muc-Wierzgoń
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2017-03-25       Impact factor: 4.291

9.  Clinical impact of tumor-infiltrating inflammatory cells in primary small cell esophageal carcinoma.

Authors:  Yuling Zhang; Hongzheng Ren; Lu Wang; Zhifeng Ning; Yixuan Zhuang; Jinfeng Gan; Shaobin Chen; David Zhou; Hua Zhu; Dongfeng Tan; Hao Zhang
Journal:  Int J Mol Sci       Date:  2014-05-30       Impact factor: 5.923

10.  M2-polarized tumor-associated macrophages facilitated migration and epithelial-mesenchymal transition of HCC cells via the TLR4/STAT3 signaling pathway.

Authors:  Rong-Rong Yao; Jing-Huan Li; Rui Zhang; Rong-Xin Chen; Yan-Hong Wang
Journal:  World J Surg Oncol       Date:  2018-01-16       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.